Literature DB >> 24069072

Anticoagulation in atrial fibrillation: NOAC's the word.

Karl Werdan1, Rüdiger Braun-Dullaeus, Peter Presek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24069072      PMCID： PMC3782018          DOI： 10.3238/arztebl.2013.0523

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  10 in total

1.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

2.  Pacemaker or defibrillator surgery without interruption of anticoagulation.

Authors:  David H Birnie; Jeff S Healey; George A Wells; Atul Verma; Anthony S Tang; Andrew D Krahn; Christopher S Simpson; Felix Ayala-Paredes; Benoit Coutu; Tiago L L Leiria; Vidal Essebag
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

3.  Effect of home testing of international normalized ratio on clinical events.

Authors:  David B Matchar; Alan Jacobson; Rowena Dolor; Robert Edson; Lauren Uyeda; Ciaran S Phibbs; Julia E Vertrees; Mei-Chiung Shih; Mark Holodniy; Philip Lavori
Journal:  N Engl J Med       Date:  2010-10-21       Impact factor: 91.245

4.  Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments.

Authors:  Sven Schmiedl; Marietta Rottenkolber; Jacek Szymanski; Werner Siegmund; Marion Hippius; Katrin Farker; Bernd Drewelow; Joerg Hasford; Petra Thürmann
Journal:  Dtsch Arztebl Int       Date:  2013-04-05       Impact factor: 5.594

Review 5.  Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

Authors:  Francesco Dentali; Nicoletta Riva; Mark Crowther; Alexander G G Turpie; Gregory Y H Lip; Walter Ageno
Journal:  Circulation       Date:  2012-10-15       Impact factor: 29.690

Review 6.  The perioperative management of treatment with anticoagulants and platelet aggregation inhibitors.

Authors:  Axel Schlitt; Csilla Jámbor; Michael Spannagl; Wiebke Gogarten; Tom Schilling; Bernhard Zwissler
Journal:  Dtsch Arztebl Int       Date:  2013-08-05       Impact factor: 5.594

Review 7.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.

Authors:  Danielle E Clarkesmith; Helen M Pattison; Deirdre A Lane
Journal:  Cochrane Database Syst Rev       Date:  2013-06-04

8.  [Dabigatran therapy--perioperative management and interpretation of coagulation tests].

Authors:  M Spannagl; R Bauersachs; E S Debus; M Gawaz; H Gerlach; S Haas; V Hach-Wunderle; E Lindhoff-Last; H Riess; S Schellong; H Schinzel; C Bode
Journal:  Hamostaseologie       Date:  2012       Impact factor: 1.778

9.  [Risk of bleeding and haemorrhagic complication with rivaroxaban--periprocedural management of haemostasis].

Authors:  J Koscielny; J Beyer-Westendorf; C von Heymann; J Braun; R Klamroth; E Lindhoff-Last; A Tiede; M Spannagl
Journal:  Hamostaseologie       Date:  2012       Impact factor: 1.778

Review 10.  New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.

Authors:  Raffaele De Caterina; Steen Husted; Lars Wallentin; Felicita Andreotti; Harald Arnesen; Fedor Bachmann; Colin Baigent; Kurt Huber; Jørgen Jespersen; Steen Dalby Kristensen; Gregory Y H Lip; João Morais; Lars Hvilsted Rasmussen; Agneta Siegbahn; Freek W A Verheugt; Jeffrey I Weitz
Journal:  J Am Coll Cardiol       Date:  2012-04-17       Impact factor: 24.094
  10 in total
  4 in total

1.  Modern education, modern media: patient empowerment in today's medicine.

Authors:  Antonius Schneider
Journal:  Dtsch Arztebl Int       Date:  2014-09-12       Impact factor: 5.594

2.  Shorter hospital stays in epistaxis patients with atrial fibrillation when taking rivaroxaban or apixaban versus phenprocoumon.

Authors:  Petar Stankovic; Robert Georgiew; Cornelius Frommelt; Sabine Hammel; Jan Wittlinger; Stephan Hoch; Danilo Obradovic; Nikolaos Dagres; Thomas Wilhelm
Journal:  J Thromb Thrombolysis       Date:  2019-04       Impact factor: 2.300

3.  Anticoagulant effect and safety assessment of an aqueous extract of Pseudocedrela kotschyi (Schweinf.) harms and Adenia cissampeloides (Planch. Ex Hook.) harms.

Authors:  Wilson Bright Nyansah; George Asumeng Koffuor; Frederick Asare; Linda Gyanfosu
Journal:  J Intercult Ethnopharmacol       Date:  2016-03-30

4.  Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK.

Authors:  Emilie Clay; Aurélien Jamotte; Peter Verhamme; Alexander T Cohen; Ben A Van Hout; Pearl Gumbs
Journal:  J Mark Access Health Policy       Date:  2018-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.